• 1
    Wood DA, Durrington P, McInnes G, et al. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998;80 (Suppl.):S129.
  • 2
    British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, The Stroke Association. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005;91(Suppl. 5):v152.
  • 3
    British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association. Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. BMJ (Clinical research ed.) 2000;320:7058.
  • 4
    Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ (Clinical research ed.) 1991;302:7668.
  • 5
    Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499502.
  • 6
    Anderson KM, Odell PM, Wilson PW, et al. Cardiovascular disease risk profiles. Am Heart J 1991; 121:2938.
  • 7
    Primatesta P, Poulter NR. Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey. BMJ (Clinical research ed.) 2000;321:13225.
  • 8
    Phatak HM, Wentworth CV, Kocevar S, et al. Prevalence of mixed dyslipidemia and predictors of lipid abnormalities in patients treated with statins in general practice. Circulation 2007;115:e253 (P145).
  • 9
    Olson KL, Bungard TJ, Tsuyuki RT. Cholesterol risk management: a systematic examination of the gap from evidence to practice. Pharmacotherapy 2001; 21:80717.
  • 10
    Northridge DB, Shandall A, Rees A, et al. Inadequate management of hyperlipidaemia after coronary bypass surgery shown by medical audit. Br Heart J 1994;72:4667.
  • 11
    Bowker TJ, Clayton TC, Ingham J, et al. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events). Heart 1996;75:33442.
  • 12
    Holt N, Johnson A, De Belder M. Patient empowerment in secondary prevention of coronary heart disease. Lancet 2000;356:314.
  • 13
    France MW, Kwok S, McElduff P, et al. Ethnic trends in lipid tests in general practice. QJM 2003;96:91923.
  • 14
    Investing in General Practice: The New General Medical Services Contract. 2003.
  • 15
    NHS. Revisions to the GMS contract, 2006/07: Delivering Investment in General Practice. 2006.
  • 16
    Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J 1998;19:1434503.
  • 17
    De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003;24:160110.